CEO SUMMARY: With the SARS-CoV-2 pandemic about to enter its eighth month in the United States, it remains difficult to predict whether the pandemic will strengthen with the fall influenza season or steadily diminish. What is clear to most pathologists and clinical laboratory executives is that the COVID-19 pandemic has already changed several aspects of how laboratories select suppliers, purchase supplies, […]
Understanding COVID-19’s Changes to Lab Industry
Having survived the cash flow collapse this winter, many lab professionals want to know: ‘What’s next?’
- By Robert Michel
- > From the Volume XXVII No. 13 - September 14, 2020 Issue
- Tags: clinical lab, clinical laboratories, Clinical Laboratory, clinical laboratory industry, clinical laboratory test, clinical labs, COVID-19 Molecular Testing, COVID-19 pandemic, COVID-19 test, covid-19 testing, COVID-19 tests, digital pathology, hospital laboratory, in vitro diagnostics companies, lab industry, lab test, lab testing, lab testing services, lab tests, laboratories, laboratory companies, laboratory industry, laboratory organization, laboratory service, laboratory services, laboratory supply chain, laboratory test, laboratory testing, laboratory tests, medical lab, medical laboratories, pathologists, Pathology group, pathology groups, pathology services, telehealth, telemedicine
